RAPT Therapeutics Stock Forward View
| RAPT Stock | USD 58.01 0.00 0.00% |
RAPT Therapeutics's Naive Prediction reference page covers the model's projected value and error measures from recent price data. The forecast output and associated deviation metrics are shown for informational use.
The Naive Prediction forecasted value of RAPT Therapeutics on the next trading day is expected to be 65.46 with a mean absolute deviation of 3.01 and the sum of the absolute errors of 183.52.This model is not at all useful as a medium-long range forecasting tool of RAPT Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict RAPT Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights. All Naive Prediction forecast figures shown for RAPT Therapeutics are reference data reflecting model output based on available historical prices. Naive Prediction Price Forecast For the 23rd of March
Given 90 days horizon, the Naive Prediction forecasted value of RAPT Therapeutics on the next trading day is expected to be 65.46 with a mean absolute deviation of 3.01 , mean absolute percentage error of 16.06 , and the sum of the absolute errors of 183.52 .Please note that although there have been many attempts to predict RAPT Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that RAPT Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest RAPT Therapeutics | RAPT Therapeutics Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of RAPT Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent RAPT Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.8869 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 3.0085 |
| MAPE | Mean absolute percentage error | 0.0683 |
| SAE | Sum of the absolute errors | 183.5181 |
RAPT Therapeutics Related Equities
Sizing up RAPT Therapeutics against these stocks within the Health Care space shows how it compares on key financial measures. Revenue and margin checks across this group help investors set expectations for RAPT Therapeutics' results. How RAPT Therapeutics ranks within this group can shift over time as the competitive picture changes. This peer set gives the context needed for a well-rounded view of RAPT Therapeutics.
| Risk & Return | Correlation |
RAPT Therapeutics Market Strength Events
For investors tracking RAPT Therapeutics, market strength indicators offer quantitative evaluation of stock behavior. By using these indicators, traders can make more informed decisions about when to buy or sell RAPT Therapeutics.
RAPT Therapeutics Risk Indicators
Analyzing RAPT Therapeutics' basic risk indicators provides investors with a structured view of the risk-return trade-off for rapt stock. By identifying the level of risk embedded in RAPT Therapeutics' investment, investors can make informed decisions about position sizing.
| Mean Deviation | 3.29 | |||
| Semi Deviation | 1.9 | |||
| Standard Deviation | 9.31 | |||
| Variance | 86.64 | |||
| Downside Variance | 12.63 | |||
| Semi Variance | 3.61 | |||
| Expected Short fall | -3.81 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for RAPT Therapeutics
Story coverage around RAPT Therapeutics often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
RAPT Therapeutics Short Properties
A short-interest review of RAPT Therapeutics provides context for understanding whether skepticism in the market is becoming more influential. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 5.1 M | |
| Cash And Short Term Investments | 231.1 M |
Additional Tools for RAPT Stock Analysis
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Prophet Use AI to generate optimal portfolios and find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |